Drug Profile
Mebendazole
Alternative Names: INGN 601Latest Information Update: 13 Oct 2021
Price :
$50
*
At a glance
- Originator Introgen Therapeutics
- Class Anthelmintics; Antineoplastics; Benzimidazoles; Carbamates
- Mechanism of Action Apoptosis stimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Cancer
Most Recent Events
- 04 Apr 2003 Preclinical trials in Cancer in USA (unspecified route). Data added to pharmacodynamic section